Clinical Trials Directory

Trials / Completed

CompletedNCT06713278

Tension-Type Headache and Masseter Thickness in Fibromyalgia

Association Between Tension-Type Headache and Masseter Muscle Thickness in Women With Fibromyalgia

Status
Completed
Phase
Study type
Observational
Enrollment
94 (actual)
Sponsor
Ankara City Hospital Bilkent · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate the relationship between tension-type headaches and masseter muscle thickness in women with fibromyalgia syndrome (FMS) and to explore the potential for new therapeutic approaches in the treatment of both headaches and FMS. Additionally, the study seeks to evaluate the impact of headaches on the quality of life in individuals with FMS. Does tension-type headache associate with increased masseter muscle thickness in women with fibromyalgia syndrome (FMS)? Does tension-type headache negatively impact the quality of life in women with FMS?

Detailed description

Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, cognitive dysfunction, and tenderness, affecting approximately 5% of the global population, predominantly women. Central sensitization plays a key role in its pathophysiology. Tension-type headaches, the most common in FMS (59.01%), are associated with pericranial muscle sensitivity, anxiety, and reduced quality of life. Increased masseter muscle activity has been observed in tension-type headaches, but its relationship with FMS remains unexplored.

Conditions

Interventions

TypeNameDescription
OTHERmasseter muscle thickness measurementmasseter muscle thickness measurement with ultrasonography
OTHERscalesheadache impact scale (HIT-6) Short SF-36 fibromyalgia total score widespread pain index symptom severity scale fibromyalgia impact questionnaire (FIQ)

Timeline

Start date
2024-05-15
Primary completion
2024-12-02
Completion
2024-12-02
First posted
2024-12-03
Last updated
2024-12-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06713278. Inclusion in this directory is not an endorsement.